U.S., Feb. 28 -- ClinicalTrials.gov registry received information related to the study (NCT06850545) titled 'Kuopio Lutetium-177 Study in Patients with PSMA-Positive Metastatic Prostate Cancer' on Feb. 22.
Brief Summary: KuPSMALu-trial is an observational study for patients treated with 177LuPSMA-I&T in Kuopio University Hospital, Finland. Study focuses on efficacy, safety and biomarker research.
Study Start Date: Jan. 10, 2020
Study Type: OBSERVATIONAL
Condition:
Metastatic Prostate Adenocarcinoma
PSMA PET-Positive Castration-Resistant Prostate Cancer
Recruitment Status: RECRUITING
Sponsor: Kuopio University Hospital
Information provided by (Responsible Party): Okko Kaariainen, Kuopio University Hospital
Published by HT Digital Co...